Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 11/27 08:08:02 am
37.755 EUR   +0.23%
07:45aSwiss drugmaker Vifor had bid interest but talks halted - sources
RE
11/26FRESENIUS SE : DZ Bank keeps its Buy rating
MD
11/24FRESENIUS SE : UBS remains Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

FRESENIUS SE : Credit Suisse reiterates its Neutral rating

10/22/2020 | 12:46pm EST

In his latest research note, analyst Christoph Gretler confirms his recommendation. The broker Credit Suisse is keeping its Neutral rating. The target price remains unchanged at EUR 45.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
CREDIT SUISSE GROUP AG 0.64% 11.735 Delayed Quote.-11.06%
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.26% 70.08 Delayed Quote.6.49%
FRESENIUS SE & CO. KGAA -0.08% 37.72 Delayed Quote.-24.93%
All news about FRESENIUS SE & CO. KGAA
07:45aSwiss drugmaker Vifor had bid interest but talks halted - sources
RE
11/26FRESENIUS SE : DZ Bank keeps its Buy rating
MD
11/24FRESENIUS SE : UBS remains Neutral
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : RBC reiterates its Neutral rating
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : Bernstein reiterates its Neutral rating
MD
11/19FRESENIUS SE : Bernstein reiterates its Buy rating
MD
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of quarter..
EQ
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of financi..
EQ
11/17FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies reiterates its Neutral rating
MD
11/13FRESENIUS SE : Receives a Buy rating from Bernstein
MD
More news
Financials
Sales 2020 36 301 M 43 285 M 43 285 M
Net income 2020 1 790 M 2 134 M 2 134 M
Net Debt 2020 24 198 M 28 854 M 28 854 M
P/E ratio 2020 11,8x
Yield 2020 2,12%
Capitalization 21 000 M 25 003 M 25 040 M
EV / Sales 2020 1,25x
EV / Sales 2021 1,12x
Nbr of Employees 309 114
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 49,67 €
Last Close Price 37,67 €
Spread / Highest target 80,5%
Spread / Average Target 31,9%
Spread / Lowest Target -53,1%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-24.93%25 003
AIER EYE HOSPITAL GROUP CO., LTD.103.94%38 900
IHH HEALTHCARE2.38%12 084
BANGKOK DUSIT MEDICAL SERVICES0.00%11 805
RAMSAY HEALTH CARE LIMITED-12.06%10 689
TOPCHOICE MEDICAL CORPORATION101.14%10 057